{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:53:38Z","timestamp":1793267618609,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymgme.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:54:45Z","timestamp":1633766085000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry"],"prefix":"10.1016","volume":"134","author":[{"given":"Aileen","family":"Kenneson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani H.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2021.10.001_bb0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archneurpsyc.1937.02260230042003","article-title":"Phenylpyruvic oligophrenia: introductory study of fifty cases of mental deficiency associated with excretion of phenylpyruvic acid","volume":"38","author":"Jervis","year":"1937","journal-title":"Arch. Neuropsych."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0015","first-page":"259","article-title":"Phenylpyruvic oligophrenia (phenylketonuria)","volume":"33","author":"Jervis","year":"1954","journal-title":"Res. Publ. Assoc. Res. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ymgme.2021.10.001_bb0025","first-page":"1089","article-title":"The efficacy of dietary therapy for phenylketonuria","volume":"104","author":"Hanley","year":"1970","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/adc.45.239.5","article-title":"Evaluation of treatment begun in first three months of life in 184 cases of phenylketonuria","volume":"45","author":"Hudson","year":"1970","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1469-8749.1970.tb01913.x","article-title":"Phenylketonuria: intellectual developmental and early treatment","volume":"12","author":"O'Grady","year":"1970","journal-title":"Dev. Med. Child Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.10.001_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","article-title":"Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning","volume":"113","author":"Therrell","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2016.04.008","article-title":"Updated, web-based nutrition management guideline for PKU: an evidence and consensus based approach","volume":"118","author":"Singh","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","article-title":"Nutritional management of PKU with glycomacropeptide from cheese whey","volume":"32","author":"Ney","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/PHMT.S49329","article-title":"Dietary intervention in the management of phenylketonuria: current perspectives","volume":"7","author":"Rocha","year":"2016","journal-title":"Pediatric. Health Med. Ther."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0060","article-title":"The financial and time burden associated with phenylketonuria treatment in the United States","volume":"21","author":"Rose","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2021.10.001_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bcp.13886","article-title":"Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: a meta-analysis of randomized controlled trials","volume":"85","author":"Qu","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.10.001_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40259-018-0292-3","article-title":"Pegvaliase: first global approval","volume":"32","author":"Markham","year":"2018","journal-title":"BioDrugs"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.10.001_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3476(00)90050-7","article-title":"Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and development outcomes","volume":"136","author":"Rouse","year":"2000","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00125817-200203000-00006","article-title":"Barriers to successful dietary control among pregnant women with phenylketonuria","volume":"4","author":"Brown","year":"2002","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2017.01.001","article-title":"Adherence to clinic recommendations among patients with phenylketonuria in the United States","volume":"120","author":"Jurecki","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13023-017-0684-3","article-title":"Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders","volume":"12","author":"Osara","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0100","series-title":"Report of a WHO Expert Committee","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry","volume":"854","year":"1995"},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/aje\/kws477","article-title":"Parent-reported height and weight as sources of bias in survey estimates of childhood obesity","volume":"178","author":"Weden","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12887-018-1042-x","article-title":"The accuracy of parent-reported height and weight for 6\u201312 year old U.S. children","volume":"18","author":"Wright","year":"2018","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl. Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/jcm3010144","article-title":"Women's attitudes regarding prenatal testing for a range of congenital disorders of varying severity","volume":"3","author":"Norton","year":"2014","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pd.5109","article-title":"Expanded carrier screening for monogenic disorders: where are we now?","volume":"38","author":"Chokoshvili","year":"2017","journal-title":"Prenat. Diagn."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0130","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s10897-017-0160-1","article-title":"Clinical utility of expanded carrier screening: reproductive behaviors of at-risk couples","volume":"27","author":"Ghiossi","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"6","key":"10.1016\/j.ymgme.2021.10.001_bb0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ejhg.2017.10","article-title":"Personal utility in genomic testing: a systematic literature review","volume":"25","author":"Kohler","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2021.10.001_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jcf.2016.02.013","article-title":"Highlighting the impact of cascade carrier testing in cystic fibrosis families","volume":"15","author":"Dugu\u00e9p\u00e9roux","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-015-9910-0","article-title":"Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency","volume":"39","author":"Coakley","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2021.10.001_bb0150","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ymgme.2012.01.006","article-title":"Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients","volume":"105","author":"de Groot","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000465529","article-title":"Micronutrients, essential fatty acids and bone health in phenylketonuria","volume":"70","author":"Demirdas","year":"2017","journal-title":"Ann. Nutr. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5114\/aoms.2011.23417","article-title":"A long-term study of bone mineral density in patients with phenylketonuria under diet therapy","volume":"7","author":"Koura","year":"2011","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jimd.12177","article-title":"Bone mineral density is within normal range in most adult phenylketonuria patients","volume":"43","author":"Lubout","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2012.12.008","article-title":"Risk factors for developing mineral bone disease in phenylketonuric patients","volume":"108","author":"Mir\u00e1s","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0175","first-page":"30","article-title":"Sex differences in body composition and bone mineral density in phenylketonuria: a cross-sectional study","volume":"15","author":"Stroup","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2021.10.001_bb0180","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/jpem-2016-0308","article-title":"Reduced bone mineral density in chinese children with phenylketonuria","volume":"30","author":"Wang","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2021.10.001_bb0185","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10545-014-9735-2","article-title":"A systematic review of bone mineral density and fractures in phenylketonuria","volume":"37","author":"Hansen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13023-015-0232-y","article-title":"Bone health in phenylketonuria: a systematic review and meta-analysis","volume":"10","author":"Demirdas","year":"2015","journal-title":"Orphanet J. Rare. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2018.09.006","article-title":"Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria","volume":"125","author":"Burton","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2021.10.001_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1020158631102","article-title":"Phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2021.10.001_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0210","first-page":"93","article-title":"Attention deficit disorder with hyperactivity symptoms in early-treated phenylketonuria patients","volume":"14","author":"Beckhauser","year":"2020","journal-title":"Iran. J. Child. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.10.001_bb0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/neu0000358","article-title":"Cognitive profile and mental health in adult phenylketonuria: a PKU-COBESCO study","volume":"31","author":"Jahja","year":"2017","journal-title":"Neuropsychology"},{"issue":"6","key":"10.1016\/j.ymgme.2021.10.001_bb0220","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/DBP.0000000000000072","article-title":"R, sharman, J, McGill, depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry","volume":"35","author":"Clacy","year":"2014","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0225","first-page":"80","article-title":"Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria","volume":"14","author":"Didycz","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0230","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10519-017-9863-1","article-title":"Long-term follow-up of cognition and mental health in adult phenylketonuria: a PKU-COBESCO study","volume":"47","author":"Jahja","year":"2017","journal-title":"Behav. Genet."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0235","doi-asserted-by":"crossref","unstructured":"R. Sharman K. Sullivan Ross&nbsp McD. Young J McGill, Depressive symptoms in adolescents with early and continuously treated phenylketonuria: Associations with phenylalanine and tyrosine levels, Gene. 504 (2012) 288-291.","DOI":"10.1016\/j.gene.2012.05.007"},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2021.10.001_bb0240","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/02643294.2017.1422709","article-title":"Language processing and executive functions in early treated adults with phenylketonuria (PKU)","volume":"35","author":"de Felice","year":"2018","journal-title":"Cogn. Neuropsychol."},{"issue":"6","key":"10.1016\/j.ymgme.2021.10.001_bb0245","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1017\/S1355617719000146","article-title":"Neuropsychological profile of children with early and continuously treated phenylketonuria: systematic review and future approaches","volume":"25","author":"Canton","year":"2019","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"5","key":"10.1016\/j.ymgme.2021.10.001_bb0250","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","article-title":"Intelligence and quality of dietary treatment in phenylketonuria","volume":"65","author":"Smith","year":"1990","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0255","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18388\/abp.2017_1524","article-title":"Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria","volume":"64","author":"Didycz","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ymgme.2021.10.001_bb0260","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ymgme.2018.12.011","article-title":"Neurocognitive functioning in adults with phenylketonuria: report of a 10-year follow-up study","volume":"126","author":"Feldman","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0265","first-page":"267","article-title":"Velasco Z\u00fa\u00f1iga, neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels","volume":"115","author":"Gonz\u00e1lez Garc\u00eda","year":"2017","journal-title":"Arch. Argent. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1037\/neu0000337","article-title":"Cognitive outcomes in early-treated adults with phenylketonuria (PKU): a comprehensive picture across domains","volume":"31","author":"Palermo","year":"2017","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.ymgme.2021.10.001_bb0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13803395.2019.1696753","article-title":"Emotional health in early-treated adults with phenylketonuria (PKU): relationship with cognitive abilities and blood phenylalanine","volume":"42","author":"Palermo","year":"2020","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.10.001_bb0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13023-019-1225-z","article-title":"Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels","volume":"14","author":"Romani","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.10.001_bb0285","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/neu0000336","article-title":"The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: effects across tasks and developmental stage","volume":"31","author":"Romani","year":"2017","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ymgme.2021.10.001_bb0290","first-page":"77","article-title":"Improved measures of brain phenylalanine and tyrosine related to neuropsychological functioning in phenylketonuria","volume":"34","author":"Waisbren","year":"2017","journal-title":"JIMD Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:08Z","timestamp":1761090668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1096719221007861"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.10.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}